558 Appendices References 1. Uppal N, Collins R, James B. Thyroid nodules: Global, economic, and personal burdens. Frontiers in endocrinology. 2023;14:1113977. https://doi.org/10.3389/fendo.2023.1113977. 2. Rossi ED, Baloch Z. The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology. Endocrine pathology. 2023;34:23-33. https://doi.org/10.1007/s12022-023-09756-2. 3. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Annals of internal medicine. 1968;69:537-540. https://doi.org/10.7326/0003-481969-3-537. 4. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clinical endocrinology. 1977;7:481-493. https://doi.org/10.1111/j.1365-2265.1977. tb01340.x. 5. Mazzaferri EL. Management of a solitary thyroid nodule. The New England journal of medicine. 1993;328:553-559. https://doi.org/10.1056/NEJM199302253280807. 6. Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154:1420-1426; discussion 1426-1427. https://doi. org/10.1016/j.surg.2013.07.006. 7. Powers AE, Marcadis AR, Lee M, Morris LGT, Marti JL. Changes in Trends in Thyroid Cancer Incidence in the United States, 1992 to 2016. JAMA. 2019;322:2440-2441. https://doi.org/10.1001/jama.2019.18528. 8. ECIS. European Cancer Information System. https://ecis.jrc.ec.europa.eu. Accessed 03/10/2023. 9. IKNL. NKR cijfers - Schildklierkanker, incidentie per jaar. https://iknl.nl/nkr-cijfers. Accessed 03/10/2023. 10. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”--screening and overdiagnosis. The New England journal of medicine. 2014;371:1765-1767. https://doi.org/10.1056/NEJMp1409841. 11. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017;317:1338-1348. https://doi.org/10.1001/jama.2017.2719. 12. Wang C, Wu Z, Lei L, Dong X, Cao W, Luo Z, et al. Geographic disparities in trends of thyroid cancer incidence and mortality from 1990 to 2019 and a projection to 2030 across income-classified countries and territories. J Glob Health. 2023;13:04108. https://doi.org/10.7189/jogh.13.04108. 13. Ullmann TM, Papaleontiou M, Sosa JA. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis. The Journal of clinical endocrinology and metabolism. 2023;108:271-280. https://doi.org/10.1210/clinem/dgac646. 14. Kovatch KJ, Hoban CW, Shuman AG. Thyroid cancer surgery guidelines in an era of de-escalation. European journal of surgical oncology. 2018;44:297-306. https://doi.org/10.1016/j.ejso.2017.03.005. 15. Durante C, Hegedus L, Czarniecka A, Paschke R, Russ G, Schmitt F, et al. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J. 2023;12. https://doi.org/10.1530/ETJ-23-0067. 16. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009;19:1159-1165. https://doi. org/10.1089/thy.2009.0274. 17. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1133. https://doi.org/10.1089/thy.2015.0020. 18. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017;27:1341-1346. https://doi.org/10.1089/thy.2017.0500. 19. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid. 2017;27:481-483. https://doi.org/10.1089/thy.2016.0628. 20. Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO classification of tumours of endocrine organs. WHO classification of tumours, 4th ed. Lyon, France: IARC; 2017. 21. Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocrine pathology. 2022;33:27-63. https://doi.org/10.1007/s12022-022-09707-3.
RkJQdWJsaXNoZXIy MTk4NDMw